Peter Hayes
Overview
Explore the profile of Peter Hayes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1877
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryan E, Gill H, Doogue R, McCann D, Murphy A, Hayes P
Pilot Feasibility Stud
. 2025 Jan;
11(1):9.
PMID: 39863908
Background: Stroke has devastating consequences for survivors. Hypertension is the most important modifiable risk factor, and its management largely takes place in primary care. However, most stroke-based research does not...
2.
Tuli S, Hayes P, ODonoghue P, Glynn F, Scully R, Murphy A, et al.
Rural Remote Health
. 2024 Nov;
24(4):8700.
PMID: 39563022
Context: Ireland has one of the most rural populations in Europe. Rurality presents challenges when accessing health services but should not be perceived as problematic and in need of a...
3.
Bhardwaj A, Hayes P, Browne J, Grealis S, Maguire D, OHora J, et al.
Physiotherapy
. 2024 Oct;
125:101416.
PMID: 39393262
Background: Barriers and facilitators of general practitioners (GPs), physiotherapists (PTs), and people with hip and knee osteoarthritis (PwOA) may influence uptake of and referral to guideline-based exercise treatments for OA....
4.
C Morrissey E, Harney O, Hogan M, Murphy P, OGrady L, Byrne M, et al.
Health Psychol Behav Med
. 2024 Sep;
12(1):2404038.
PMID: 39315072
Background: Hypertension remains one of the most important modifiable risk factors for stroke and heart disease. Anti-hypertensive medications are effective, but are often not used to maximum benefit. Sub-optimal dosing...
5.
Kennedy C, Hayes P, Cicero A, Dobner S, le Roux C, McEvoy J, et al.
Eur Heart J
. 2024 Sep;
45(38):4124-4134.
PMID: 39217502
Background And Aims: Randomized clinical trials (RCTs) assessing semaglutide reported reductions of systolic blood pressure (SBP) in trial populations with baseline blood pressure in the normotensive range. This study aimed...
6.
Hayes P, Ferrara A, Keating A, McKnight K, ORegan A
Rev Cardiovasc Med
. 2024 Jul;
23(9):302.
PMID: 39077709
Hypertension and physical inactivity are leading causes of premature mortality. While both are modifiable risk factors for cardiovascular disease, their prevalence remains high. As populations grow older, they are more...
7.
Toomey C, Bhardwaj A, Browne J, Dowling I, Grealis S, Hayes P, et al.
BMJ Open
. 2024 Jul;
14(7):e080646.
PMID: 38969380
Objectives: To identify within-stakeholder agreement and between-stakeholder differences in beliefs regarding exercise for osteoarthritis among general practitioners (GPs), physiotherapists (PTs) and people with hip and knee osteoarthritis (PwOA). A secondary...
8.
Morrissey E, Murphy A, Murphy P, OGrady L, Byrne M, Casey M, et al.
HRB Open Res
. 2024 May;
6:6.
PMID: 38779427
Hypertension is one of the most important risk factors for stroke and heart disease. Recent international guidelines have stated that The MaxImising Adherence, Minimising Inertia (MIAMI) intervention, which has been...
9.
Tripathi D, Patch D, Mehrzad H, Yu D, Aspinall R, Armstrong M, et al.
BMJ Open Gastroenterol
. 2024 Mar;
11(1).
PMID: 38519049
Introduction: In liver cirrhosis, acute variceal bleeding (AVB) is associated with a 1-year mortality rate of up to 40%. Data on early or pre-emptive transjugular intrahepatic portosystemic stent-shunt (TIPSS) in...
10.
Konya J, McDonagh S, Hayes P, Debus S, Aboyans V, Clark C
BJGP Open
. 2024 Mar;
8(2).
PMID: 38438198
Background: Peripheral artery disease (PAD) is common and associated with future cardiovascular events. PAD is underdiagnosed, which limits opportunities to address secondary prevention of cardiovascular disease. It is unknown how...